List of Tables
    Table 1. Breast Cancer Therapeutics Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Breast Cancer Therapeutics Drugs Market Trends
    Table 3. Breast Cancer Therapeutics Drugs Market Drivers
    Table 4. Breast Cancer Therapeutics Drugs Market Challenges
    Table 5. Breast Cancer Therapeutics Drugs Market Restraints
    Table 6. Global Breast Cancer Therapeutics Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Breast Cancer Therapeutics Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Breast Cancer Therapeutics Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Breast Cancer Therapeutics Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Breast Cancer Therapeutics Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Breast Cancer Therapeutics Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Breast Cancer Therapeutics Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Breast Cancer Therapeutics Drugs Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Breast Cancer Therapeutics Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Breast Cancer Therapeutics Drugs Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Breast Cancer Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Breast Cancer Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Therapeutics Drugs as of 2021)
    Table 18. Top Players of Breast Cancer Therapeutics Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Breast Cancer Therapeutics Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Breast Cancer Therapeutics Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Breast Cancer Therapeutics Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Breast Cancer Therapeutics Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Breast Cancer Therapeutics Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Breast Cancer Therapeutics Drugs Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Breast Cancer Therapeutics Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Breast Cancer Therapeutics Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Breast Cancer Therapeutics Drugs Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Breast Cancer Therapeutics Drugs Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Breast Cancer Therapeutics Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Breast Cancer Therapeutics Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Breast Cancer Therapeutics Drugs Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Breast Cancer Therapeutics Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Breast Cancer Therapeutics Drugs Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Breast Cancer Therapeutics Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Breast Cancer Therapeutics Drugs Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Breast Cancer Therapeutics Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Breast Cancer Therapeutics Drugs Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Breast Cancer Therapeutics Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Breast Cancer Therapeutics Drugs Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Breast Cancer Therapeutics Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Bayer HealthCare Corporation Information
    Table 43. Bayer HealthCare Description and Business Overview
    Table 44. Bayer HealthCare Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. Bayer HealthCare Breast Cancer Therapeutics Drugs Product
    Table 46. Bayer HealthCare Recent Development
    Table 47. Eli Lily Corporation Information
    Table 48. Eli Lily Description and Business Overview
    Table 49. Eli Lily Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Eli Lily Product
    Table 51. Eli Lily Recent Development
    Table 52. Pfizer Corporation Information
    Table 53. Pfizer Description and Business Overview
    Table 54. Pfizer Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Pfizer Product
    Table 56. Pfizer Recent Development
    Table 57. Novartis Corporation Information
    Table 58. Novartis Description and Business Overview
    Table 59. Novartis Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Novartis Product
    Table 61. Novartis Recent Development
    Table 62. Eisai Corporation Information
    Table 63. Eisai Description and Business Overview
    Table 64. Eisai Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Eisai Product
    Table 66. Eisai Recent Development
    Table 67. Halozyme Therapeutics Corporation Information
    Table 68. Halozyme Therapeutics Description and Business Overview
    Table 69. Halozyme Therapeutics Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Halozyme Therapeutics Product
    Table 71. Halozyme Therapeutics Recent Development
    Table 72. Roche Corporation Information
    Table 73. Roche Description and Business Overview
    Table 74. Roche Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. Roche Product
    Table 76. Roche Recent Development
    Table 77. Puma Biotechnology Corporation Information
    Table 78. Puma Biotechnology Description and Business Overview
    Table 79. Puma Biotechnology Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. Puma Biotechnology Product
    Table 81. Puma Biotechnology Recent Development
    Table 82. Janssen Biotech Corporation Information
    Table 83. Janssen Biotech Description and Business Overview
    Table 84. Janssen Biotech Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. Janssen Biotech Product
    Table 86. Janssen Biotech Recent Development
    Table 87. AbbVie Corporation Information
    Table 88. AbbVie Description and Business Overview
    Table 89. AbbVie Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. AbbVie Product
    Table 91. AbbVie Recent Development
    Table 92. BioMarin Corporation Information
    Table 93. BioMarin Description and Business Overview
    Table 94. BioMarin Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 95. BioMarin Product
    Table 96. BioMarin Recent Development
    Table 97. Array BioPharma Corporation Information
    Table 98. Array BioPharma Description and Business Overview
    Table 99. Array BioPharma Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 100. Array BioPharma Product
    Table 101. Array BioPharma Recent Development
    Table 102. Merck Corporation Information
    Table 103. Merck Description and Business Overview
    Table 104. Merck Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 105. Merck Product
    Table 106. Merck Recent Development
    Table 107. Syndax Corporation Information
    Table 108. Syndax Description and Business Overview
    Table 109. Syndax Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 110. Syndax Product
    Table 111. Syndax Recent Development
    Table 112. MacroGenics Corporation Information
    Table 113. MacroGenics Description and Business Overview
    Table 114. MacroGenics Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 115. MacroGenics Product
    Table 116. MacroGenics Recent Development
    Table 117. ImmunoGen Corporation Information
    Table 118. ImmunoGen Description and Business Overview
    Table 119. ImmunoGen Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 120. ImmunoGen Product
    Table 121. ImmunoGen Recent Development
    Table 122. Santen Pharma Corporation Information
    Table 123. Santen Pharma Description and Business Overview
    Table 124. Santen Pharma Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 125. Santen Pharma Product
    Table 126. Santen Pharma Recent Development
    Table 127. Celgene Corporation Information
    Table 128. Celgene Description and Business Overview
    Table 129. Celgene Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 130. Celgene Product
    Table 131. Celgene Recent Development
    Table 132. Oncothyreon Corporation Information
    Table 133. Oncothyreon Description and Business Overview
    Table 134. Oncothyreon Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 135. Oncothyreon Product
    Table 136. Oncothyreon Recent Development
    Table 137. AstraZeneca Corporation Information
    Table 138. AstraZeneca Description and Business Overview
    Table 139. AstraZeneca Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 140. AstraZeneca Product
    Table 141. AstraZeneca Recent Development
    Table 142. Sprint Bioscience Corporation Information
    Table 143. Sprint Bioscience Description and Business Overview
    Table 144. Sprint Bioscience Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 145. Sprint Bioscience Product
    Table 146. Sprint Bioscience Recent Development
    Table 147. Genentech Corporation Information
    Table 148. Genentech Description and Business Overview
    Table 149. Genentech Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 150. Genentech Product
    Table 151. Genentech Recent Development
    Table 152. Galena Biopharma Corporation Information
    Table 153. Galena Biopharma Description and Business Overview
    Table 154. Galena Biopharma Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 155. Galena Biopharma Product
    Table 156. Galena Biopharma Recent Development
    Table 157. Lycera Corporation Information
    Table 158. Lycera Description and Business Overview
    Table 159. Lycera Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 160. Lycera Product
    Table 161. Lycera Recent Development
    Table 162. CTI BioPharma Corporation Information
    Table 163. CTI BioPharma Description and Business Overview
    Table 164. CTI BioPharma Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 165. CTI BioPharma Product
    Table 166. CTI BioPharma Recent Development
    Table 167. Key Raw Materials Lists
    Table 168. Raw Materials Key Suppliers Lists
    Table 169. Breast Cancer Therapeutics Drugs Customers List
    Table 170. Breast Cancer Therapeutics Drugs Distributors List
    Table 171. Research Programs/Design for This Report
    Table 172. Key Data Information from Secondary Sources
    Table 173. Key Data Information from Primary Sources
List of Figures
    Figure 1. Breast Cancer Therapeutics Drugs Product Picture
    Figure 2. Global Breast Cancer Therapeutics Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Breast Cancer Therapeutics Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Breast Cancer Therapeutics Drugs Sales 2017-2028 (K MT)
    Figure 5. United States Breast Cancer Therapeutics Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Breast Cancer Therapeutics Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Breast Cancer Therapeutics Drugs Sales 2017-2028 (K MT)
    Figure 8. United States Breast Cancer Therapeutics Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Breast Cancer Therapeutics Drugs Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Breast Cancer Therapeutics Drugs Report Years Considered
    Figure 11. Product Picture of Mitotic Inhibitors
    Figure 12. Product Picture of Anti-Metabolites
    Figure 13. Product Picture of Hormone Receptor
    Figure 14. Product Picture of Aromatase Inhibitors
    Figure 15. Product Picture of HER2 Inhibitors
    Figure 16. Global Breast Cancer Therapeutics Drugs Market Share by Type in 2022 & 2028
    Figure 17. Global Breast Cancer Therapeutics Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Breast Cancer Therapeutics Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Breast Cancer Therapeutics Drugs Sales by Type (2017-2028) & (K MT)
    Figure 20. Global Breast Cancer Therapeutics Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Breast Cancer Therapeutics Drugs Price by Type (2017-2028) & (USD/MT)
    Figure 22. United States Breast Cancer Therapeutics Drugs Market Share by Type in 2022 & 2028
    Figure 23. United States Breast Cancer Therapeutics Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Breast Cancer Therapeutics Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Breast Cancer Therapeutics Drugs Sales by Type (2017-2028) & (K MT)
    Figure 26. United States Breast Cancer Therapeutics Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Breast Cancer Therapeutics Drugs Price by Type (2017-2028) & (USD/MT)
    Figure 28. Product Picture of Phase I
    Figure 29. Product Picture of Phase II
    Figure 30. Product Picture of Phase III
    Figure 31. Global Breast Cancer Therapeutics Drugs Market Share by Application in 2022 & 2028
    Figure 32. Global Breast Cancer Therapeutics Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Breast Cancer Therapeutics Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Breast Cancer Therapeutics Drugs Sales by Application (2017-2028) & (K MT)
    Figure 35. Global Breast Cancer Therapeutics Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Breast Cancer Therapeutics Drugs Price by Application (2017-2028) & (USD/MT)
    Figure 37. United States Breast Cancer Therapeutics Drugs Market Share by Application in 2022 & 2028
    Figure 38. United States Breast Cancer Therapeutics Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Breast Cancer Therapeutics Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Breast Cancer Therapeutics Drugs Sales by Application (2017-2028) & (K MT)
    Figure 41. United States Breast Cancer Therapeutics Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Breast Cancer Therapeutics Drugs Price by Application (2017-2028) & (USD/MT)
    Figure 43. North America Breast Cancer Therapeutics Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 44. North America Breast Cancer Therapeutics Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Breast Cancer Therapeutics Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 48. Europe Breast Cancer Therapeutics Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Breast Cancer Therapeutics Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 55. Asia-Pacific Breast Cancer Therapeutics Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. China Taiwan Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Breast Cancer Therapeutics Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 66. Latin America Breast Cancer Therapeutics Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Breast Cancer Therapeutics Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 71. Middle East & Africa Breast Cancer Therapeutics Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. UAE Breast Cancer Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Breast Cancer Therapeutics Drugs Value Chain
    Figure 76. Breast Cancer Therapeutics Drugs Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed